Artificial Insemination Market –
Regional Insights
On the basis of the region, the
global Artificial
Insemination Market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa. North America market holds the dominant
position in the global artificial insemination market, owing to technological
advancements and favorable rules and regulations in the region. For instance,
according to 2018 National Conference of State Legislature report, 14 states
have laws mandating that employers offer insurance for fertility treatment.
Hawaii, Arkansas, Texas, and Maryland mandate coverage for in vitro
fertilization only, excluding inseminations.
Furthermore, Asia Pacific
artificial insemination market is projected to witness significant growth owing
to increasing prevalence of infertility among the populace and less stringent
regulations. For instance, according to the United Nation Department of Economic
and Social Affairs 2015 report shows a fertility rate decline from 1.3 to 1.4
children per woman.
Artificial insemination is a
medical process for the purpose of achieving pregnancy through intentional
introduction of sperm in a female’s uterus by means other than sexual intercourse.
Artificial insemination is a fertility treatment process for humans, and is a
usual practice for animal breeding. Recipients of artificial insemination
include single mothers and infertile couples. Intrauterine Insemination (IUI)
is the most widely operated method of artificial insemination. Increase
prevalence of infertility is a key factor contributing to growth of artificial
insemination market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1793
For instance, according to
research published in 2012 PLOS Medicine, around 48.5 million couples worldwide
were unable to conceive a child in 2010. Market players often offer home-use
kits, including ovulation kits, pregnancy detection kits, and insemination
devices.
Artificial Insemination Market
Dynamics
Major pharmaceutical companies
are vigorously developing products that are in clinical and preclinical trials
and launching new insemination kits that have demonstrated potential benefits,
which in turn is propelling the artificial insemination market growth. For
instance, 2015 clinical trial study of Stork OTC kit showed effectiveness at
delivering higher concentration of sperm to the cervix than natural
intercourse. The Stork OTC delivered 3.23x higher value of sperm concentration
to around 85% of the subjects in the study, whereas the remaining 15% showed no
change in sperm concentration at the cervix. The Stork OTC received FDA
over-the-counter approval in July 2014. The kit helps collect, insert, and
transport sperms directly at the opening of the cervix for prolong duration,
providing sperms the opportunity to enter into the uterus. The Stork OTC
provides a safe and simple way for users to avoid unfavorable vaginal environment,
to deliver the sperm.
Moreover, according to the
National Women’s Health Resource Center, infertility impacts over 20 million
women. According to 2017 United Nations World Population prospects report,
total fertility is expected to decrease from 2.43 to 2.39 (children per woman)
between 2020 and 2030. Increasing incidence of infertility among the global
populace is majorly boosting growth of the artificial insemination market.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/artificial-insemination-market-1793
However, stringent regulations
being implemented by most countries regarding who is applicable to receive
fertility treatments, is hindering growth of the artificial insemination market
size. For instance, Italy and France forbid lesbian couples and single women
from using artificial insemination. Italy and Austria are among those banning
all sperm and egg donations for IVF. Norway and Germany ban egg donations, however,
allow sperm donations.
Artificial Insemination Market –
Competitive Landscape
Key players operating in the
global artificial insemination market include Pride Angel, Irvine Scientific,
Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility,
Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon
Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. Key players are
adoption growth strategies such as collaborations, acquisition, and new product
launches to maintain a dominant position in the market. For instance, in 2016,
Worthington Industries, in collaboration with Intellectual Ventures, launched
the innovative AIS 3 and AIS 1.5 artificial insemination shield refrigerators
equipped with the advanced artificial insemination shield canisters for holding
samples.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1793
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment